Data Sharing Project Part 2

March 25, 2022 updated by: King's College London

Investigating Service User Opinions on Sharing Levels of Personal Information

Patient data from clinical records are increasingly recognised as a valuable resource and a number of global initiatives exist to promote and enable the sharing of data. However, some mental health service-users have expressed concerns about the use of their data by services, but these have not been explored in depth and the acceptable limits of data sharing remain unclear. The purpose of the study is to present different approaches to data sharing, with examples taken from across the world, varying in levels of anonymity and amounts of data stored and shared, with a view to extracting relevant principles directly from mental health service users. The primary objective of this study is to understand from service-users the limits of acceptable pseudonymised data sharing and data collection methods. This will inform the wider scientific community about any emerging questions and issues on pseudonymised clinical data sharing. We aim to explore the level of benefit service-users would accept, in exchange for the level of pseudonymised data they provide. Additionally, this study aims to investigate what service-users consider "identifiable" data, for example whether they consider demographic or location data or purely their real name to be identifiable. This study will ensure service-user views are an integral contribution to future pseudonymised data sharing systems, maximising applicability and acceptability. This study will use qualitative methods, in the form of focus groups, to gather service-user views. Focus groups will consider what participants believe to be identifiable data, who should get access, how should individuals and/or companies get access, how should data be protected and whether these answers change if pertaining to mental health information. Focus group data will be analysed using thematic analysis. Themes produced will be presented to participants in a second focus group. Participants will be encouraged to expand or change anything.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

We want to capture the views of a broad range of service users who have used mental health services or have experienced mental health problems from diverse backgrounds (ethnicity, age and clinical diagnoses).

Description

Inclusion Criteria:

  • Individuals who have experience of using mental health services or experienced mental health difficulties in the past.
  • Aged 18 and above.
  • Able to give informed consent.
  • Ability to speak fluent English.

Exclusion Criteria:

  • If identified through C4C, participants whose care team specify concerns regarding taking part in the study.
  • People in whom significant concerns have been raised relating to risk, where risk refers to the extent to which an individual poses a threat to themselves (e.g. self-harm or suicidal intent).
  • Inability to give informed consent, as judged by the clinician responsible for a service user's ongoing care, where applicable.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental health service user opinions on clinical data sharing as explored through qualitative focus groups questions
Time Frame: Through study completion, an average of 1 year

To understand the requirements of service users, on issues such as privacy, usability, and acceptability of different tiers of data sharing. Furthermore, to investigate what service-users consider "identifiable" data, for example whether they consider identifiable data to be demographic information, location data (consisting of relative and absolute data) or purely their real name.

This will be achieved by conducting a focus group in which the participants will be asked about hypothetical models of data sharing and their opinions on it. This will be guided by a topic guide asking the following questions:

  1. What is data? What would you consider to be personally identifiable information?
  2. Who gets access?
  3. How should individuals and/or companies get access?
  4. How should data be protected? The focus group will be audio-recorded, transcribed and analysed (via thematic analysis) to answer the primary outcome.
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Til Wykes, Clinical Doc, King's College London

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2022

Primary Completion (Anticipated)

November 1, 2022

Study Completion (Anticipated)

November 1, 2022

Study Registration Dates

First Submitted

March 8, 2022

First Submitted That Met QC Criteria

March 25, 2022

First Posted (Actual)

March 28, 2022

Study Record Updates

Last Update Posted (Actual)

March 28, 2022

Last Update Submitted That Met QC Criteria

March 25, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • LRS/DP-21/22-26411
  • 310873 (Other Identifier: IRAS)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on Not applicable - qualitative research study

3
Subscribe